journal article·2023-12

Preparation of hyaluronic acid-decorated hollow meso-organosilica/poly(methacrylic acid) nanospheres with redox/pH dual responsivity for delivery of curcumin to breast cancer cells

Vahab Ghalehkhondabi, Alireza Fazlali, Meysam Soleymani

Publisher page

Abstract

Present cancer treatment using chemotherapy is limited owing to serious adverse effects on normal cells. To manage this problem, targeted drug delivery using smart polymeric nanoparticles and/or mesoporous silica nanoparticles can play a key role. In this study, a combination of surfactant-directed sol-gel and seeded precipitation polymerization techniques were designed to synthesize hyaluronic acid-decorated pH and redox dual-stimuli responsive hollow mesoporous organosilica/poly(methacrylic acid) nanospheres for active-targeted delivery of curcumin to breast cancer cells. The obtained nanospheres possess diameter less than 200 nm, high negative zeta potential (−30 mV), and narrow size distribution. The prepared nanospheres exhibited a high entrapment efficiency up to 70 % and drug loading capacity more than 10 % for curcumin. In vitro drug release studies showed that, the cumulative drug release was remarkably restricted under normal physiological media (neutral pH and in the absence of glutathione), while it was accelerated at the simulated tumor tissue conditions (acidic pH and in the presence of glutathione), indicating redox and pH-responsivity of the prepared nanocarrier. In vitro cytotoxicity and apoptosis assays demonstrated that the empty nanospheres have excellent biocompatibility, and curcumin-loaded targeted nanospheres are more cytotoxic against MCF-7 human breast cancer cells compared to the free drug and non-targeted nanospheres.
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Understanding breast cancer: from conventional therapies to repurposed drugs10.1016/j.ejps.2020.105401 ↗
3. Nanomedicine applications in the treatment of breast cancer: current state of the art10.2147/IJN.S123437 ↗
4. Nanocarriers for delivery of herbal based drugs in breast cancer-an overview
5. Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery10.1016/j.jcis.2011.04.006 ↗
6. Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles10.1016/j.biomaterials.2012.10.068 ↗
7. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment10.1016/j.biomaterials.2013.12.090 ↗
8. In vivo evaluation of a self-nanoemulsifying drug delivery system for curcumin10.1016/j.biopha.2017.01.102 ↗
9. Recent advances in colloidal delivery systems for nutraceuticals: a case study–delivery by design of curcumin10.1016/j.jcis.2019.09.045 ↗
10. Carrier‐free nanoassembly of curcumin–erlotinib conjugate for cancer targeted therapy10.1002/adhm.202001128 ↗
11. Curcumin polymers as anticancer conjugates10.1016/j.biomaterials.2010.06.007 ↗
12. Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer10.1016/j.ijpharm.2014.01.009 ↗
13. Thermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction10.1016/j.actbio.2013.10.020 ↗
14. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer10.1016/j.biomaterials.2014.06.040 ↗
15. pH-responsive prodrug nanoparticles based on xylan-curcumin conjugate for the efficient delivery of curcumin in cancer therapy10.1016/j.carbpol.2018.02.006 ↗
16. Polyethylene glycol conjugated polymeric nanocapsules for targeted delivery of quercetin to folate-expressing cancer cells in vitro and in vivo10.1021/nn405155b ↗
17. Nanotechnology-applied curcumin for different diseases therapy10.1155/2014/394264 ↗
18. Y-shaped biotin-conjugated poly (ethylene glycol)–poly (epsilon-caprolactone) copolymer for the targeted delivery of curcumin10.1016/j.jcis.2014.11.073 ↗
19. Synthesis of chitin-glucan-aldehyde-quercetin conjugate and evaluation of anticancer and antioxidant activities10.1016/j.carbpol.2018.03.092 ↗
20. pH-responsive polymer–drug conjugates: design and progress10.1016/j.jconrel.2015.12.024 ↗
21. Mechanisms of drug release in pH-sensitive micelles for tumour targeted drug delivery system: a review10.1016/j.ijpharm.2017.11.003 ↗
22. Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review10.1016/j.biomaterials.2016.01.061 ↗
23. Polymer-coated hollow mesoporous silica nanoparticles for triple-responsive drug delivery10.1021/acsami.5b05893 ↗
24. pH-sensitive poly (glutamic acid) grafted mesoporous silica nanoparticles for drug delivery10.1016/j.ijpharm.2013.04.014 ↗
25. Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery10.1016/j.matdes.2019.108187 ↗
26. Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer10.1016/j.biomaterials.2015.05.022 ↗
27. Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy10.1016/j.jconrel.2017.05.006 ↗
28. Enhanced uptake in 2D-and 3D-lung cancer cell models of redox responsive PEGylated nanoparticles with sensitivity to reducing extra-and intracellular environments10.1016/j.jconrel.2018.03.011 ↗
29. Redox‐responsive nanoparticle‐mediated systemic RNAi for effective cancer therapy10.1002/smll.201802565 ↗
30. Redox-sensitive micelles based on retinoic acid modified chitosan conjugate for intracellular drug delivery and smart drug release in cancer therapy10.1016/j.carbpol.2019.03.064 ↗
31. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel10.1016/j.biomaterials.2011.11.022 ↗
32. Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles10.1016/j.biomaterials.2014.06.036 ↗
33. Redox-responsive polyanhydride micelles for cancer therapy10.1016/j.biomaterials.2013.12.025 ↗
34. Redox-sensitive hydroxyethyl starch–doxorubicin conjugate for tumor targeted drug delivery10.1021/acsami.6b11932 ↗
35. Enzymatically disulfide-crosslinked chitosan/hyaluronic acid layer-by-layer self-assembled microcapsules for redox-responsive controlled release of protein10.1021/acsami.8b07120 ↗
36. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery10.1016/j.biomaterials.2013.01.084 ↗
37. Hollow‐structured mesoporous materials: chemical synthesis, functionalization and applications10.1002/adma.201305319 ↗
38. Hollow mesoporous organosilica nanoparticles: a generic intelligent framework-hybridization approach for biomedicine10.1021/ja508721y ↗
39. Acidity/reducibility dual-responsive hollow mesoporous organosilica nanoplatforms for tumor-specific self-assembly and synergistic therapy10.1021/acsnano.8b06058 ↗
40. Facile synthesis of monodisperse hollow mesoporous organosilica/silica nanospheres by an in situ dissolution and reassembly approach10.1021/acsami.8b21906 ↗
41. Functionalized MoS2 nanosheet-capped periodic mesoporous organosilicas as a multifunctional platform for synergistic targeted chemo-photothermal therapy10.1016/j.cej.2018.02.052 ↗
42. Facile preparation of near-infrared fluorescence and magnetic resonance dual-modality imaging probes based on mesoporous organosilica nanoparticles10.1016/j.jcis.2018.12.067 ↗
43. Mesoporous silica hollow spheres with ordered radial mesochannels by a spontaneous self-transformation approach10.1021/cm303338v ↗
44. A facile multi-interface transformation approach to monodisperse multiple-shelled periodic mesoporous organosilica hollow spheres10.1021/jacs.5b05369 ↗
45. Synthesis of organo-functionalized mesoporous silica hollow nanospheres via in situ generated template method10.1007/s10934-017-0552-5 ↗
46. Deformable hollow periodic mesoporous organosilica nanocapsules for significantly improved cellular uptake10.1021/jacs.7b10694 ↗
47. Small-sized deformable hollow mesoporous organosilica nanocapsules with improved cellular uptake10.1007/s10934-020-00953-6 ↗
48. General and facile syntheses of hybridized deformable hollow mesoporous organosilica nanocapsules for drug delivery10.1016/j.jcis.2020.09.060 ↗
49. Facile synthesis of yolk–shell structured monodisperse mesoporous organosilica nanoparticles by a mild alkalescent etching approach10.1016/j.jcis.2018.05.024 ↗
50. Facile fabrication of core/shell structured SiO 2/polypyrrole nanoparticles with surface modification and their electrorheology10.1039/C6RA10349A ↗
51. Folic acid-conjugated pH-responsive poly (methacrylic acid) nanospheres for targeted delivery of anticancer drugs to breast cancer cells10.1016/j.molliq.2021.118028 ↗
52. Folate-targeted nanomicelles containing silibinin as an active drug delivery system for liver cancer therapy
53. Hyaluronic acid-curcumin conjugate suppresses the fibrotic functions of myofibroblasts from contractive joint by the PTGER2 demethylation10.1093/rb/rbz016 ↗
54. Effects of multiple injections on the efficacy and cytotoxicity of folate-targeted magnetite nanoparticles as theranostic agents for MRI detection and magnetic hyperthermia therapy of tumor cells10.1038/s41598-020-58605-3 ↗
55. Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability10.1016/j.jcis.2011.03.071 ↗
56. Curcumin loaded mesoporous silica: an effective drug delivery system for cancer treatment10.1039/C5BM00552C ↗
57. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment10.1080/21691401.2017.1290648 ↗
58. Development and evaluation of hollow mesoporous silica microspheres bearing on enhanced oral delivery of curcumin10.1080/03639045.2018.1539098 ↗
59. Preparation of hyaluronic acid-decorated mixed nanomicelles for targeted delivery of hydrophobic drugs to CD44-overexpressing cancer cells10.1016/j.ijpharm.2020.120052 ↗
60. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
61. Kinetic modeling on drug release from controlled drug delivery systems
62. Bruschi · 2015 · 63
63. Controlled anti-cancer drug release through advanced nano-drug delivery systems: static and dynamic targeting strategies10.1016/j.jconrel.2020.08.012 ↗
64. Preparation of hollow mesoporous silica spheres by a sol–gel/emulsion approach10.1016/j.micromeso.2009.06.028 ↗
65. Controllable synthesis of hollow mesoporous silica spheres and application as support of nano-gold10.1016/j.jssc.2014.03.003 ↗
66. Controllable synthesis of hollow periodic mesoporous organosilica spheres with radial mesochannels and their degradable behavior10.1039/C8TA02569J ↗
67. Small size mesoporous organosilica nanorods with different aspect ratios: synthesis and cellular uptake10.1016/j.jcis.2017.10.006 ↗
68. Yolk–shell structured mesoporous nanoparticles with thioether-bridged organosilica frameworks10.1021/cm502777e ↗
69. Facile synthesis of mesoporous organosilica nanobowls with bridged silsesquioxane framework by one-pot growth and dissolution mechanism10.1016/j.jcis.2018.05.104 ↗
70. Cisplatin and doxorubicin high-loaded nanodrug based on biocompatible thioether-and ethane-bridged hollow mesoporous organosilica nanoparticles10.1016/j.jcis.2017.10.116 ↗
71. Core–shell particles for drug-delivery, bioimaging, sensing, and tissue engineering10.1039/C9BM01872G ↗
72. Reparation of silica/poly (methacrylic acid)/poly (divinylbenzene-co-methacrylic acid) tri-layer microspheres and the corresponding hollow polymer microspheres with movable silica core10.1007/s10118-010-9164-0 ↗
73. A controlled morphology of polymeric nanocapsules via the density of surface vinyl group for the precipitation polymerization10.1016/j.polymer.2013.06.035 ↗
74. Synthesis of a Au/silica/polymer trilayer composite and the corresponding hollow polymer microsphere with a movable Au core10.1021/la7025957 ↗
75. Preparation of silica/polymer hybrid microspheres and the corresponding hollow polymer microspheres with functional groups10.1002/pat.1233 ↗
76. Redox‐and temperature‐controlled drug release from hollow mesoporous silica nanoparticles10.1002/chem.201301060 ↗
77. A one-step synthesis of hollow periodic mesoporous organosilica spheres with radially oriented mesochannels10.1039/C5CC10106A ↗
78. Mesoporous organosilica nanoparticles with large radial pores via an assembly-reconstruction process in bi-phase10.1039/C6TB03327J ↗
79. Hollow periodic mesoporous organosilica nanospheres by a facile emulsion approach10.1016/j.jcis.2016.04.026 ↗
80. pH-responsive hollow polymeric microspheres and concentric hollow silica microspheres from silica− polymer core− shell microspheres10.1021/la8010579 ↗
81. Alternating silica/polymer multilayer hybrid microspheres templates for double-shelled polymer and inorganic hollow microstructures10.1021/cm903501e ↗
82. A general method for the synthesis of various rattle-type microspheres and their diverse applications10.1039/c3ra42997k ↗
83. Facile synthesis of silica/polymer hybrid microspheres and hollow polymer microspheres10.1016/j.polymer.2007.07.068 ↗
84. Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release10.1016/j.msec.2016.04.091 ↗
85. Chitosan capped pH-responsive hollow mesoporous silica nanoparticles for targeted chemo-photo combination therapy10.1016/j.carbpol.2019.115706 ↗
86. Chitosan-capped enzyme-responsive hollow mesoporous silica nanoplatforms for colon-specific drug delivery10.1186/s11671-020-03351-8 ↗
87. Tumor targeted delivery of umbelliferone via a smart mesoporous silica nanoparticles controlled-release drug delivery system for increased anticancer efficiency10.1016/j.msec.2020.111239 ↗
88. Facile synthesis of functional silica/polymer composite materials and hydrophilic hollow polymer microspheres10.1002/app.29255 ↗
89. Magnetic core-shell S-nitrosothiols nanoparticles as tumor dual-targeting theranostic platform10.1016/j.colsurfb.2019.05.075 ↗
90. Ag@ S-nitrosothiol core–shell nanoparticles for chemo and photothermal synergistic tumor targeted therapy10.1039/D0TB00734J ↗
91. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3, 4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells10.1016/j.colsurfb.2015.09.043 ↗
92. Hyaluronic acid-decorated laponite® nanocomposites for targeted anticancer drug delivery10.3390/polym11010137 ↗
93. Preparation of magnetically doped multilayered functional silica particles via surface modification with organic polymer10.1002/pat.3067 ↗
94. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts10.1016/j.jconrel.2015.01.012 ↗
95. Smart cancer cell targeting imaging and drug delivery system by systematically engineering periodic mesoporous organosilica nanoparticles10.1021/acsami.5b09585 ↗
96. Hyaluronic acid-modified polymeric gatekeepers on biodegradable mesoporous silica nanoparticles for targeted cancer therapy10.1021/acsbiomaterials.8b00218 ↗
97. A cationic surfactant assisted selective etching strategy to hollow mesoporous silica spheres10.1039/c0nr00893a ↗
98. Hyaluronic acid and carbon dots-gated hollow mesoporous silica for redox and enzyme-triggered targeted drug delivery and bioimaging10.1016/j.msec.2017.04.059 ↗
99. A novel method for in situ encapsulation of curcumin in magnetite-silica core-shell nanocomposites: a multifunctional platform for controlled drug delivery and magnetic hyperthermia therapy10.1016/j.molliq.2020.114731 ↗
100. Investigation of different core-shell toward Janus morphologies by variation of surfactant and feeding composition: a study on the kinetics of DOX release10.1016/j.colsurfb.2018.06.064 ↗